Incidence of bone pain. Pain symptoms were evaluated before administration of filgrastim each day and at each follow-up after donation. (A) Percentage of PBSC donors who experienced bone pain. (B) Site of bone pain frequency on Day 4. (C) Frequency of highest severity of bone pain during mobilization and collection.